2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee

Dharam J Kumbhani; Christopher P Cannon; Craig J Beavers; Deepak L Bhatt; Adam Cuker; Ty J Gluckman; Joseph E Marine; Roxana Mehran; Steven R Messe; Nimesh S Patel; Benjamin E Peterson; Kenneth Rosenfield; Sarah A Spinler; Vinod H Thourani

doi:10.1016/j.jacc.2020.09.011

2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee

J Am Coll Cardiol. 2021 Feb 9;77(5):629-658. doi: 10.1016/j.jacc.2020.09.011. Epub 2020 Nov 26.

Authors

Dharam J Kumbhani, Christopher P Cannon, Craig J Beavers, Deepak L Bhatt, Adam Cuker, Ty J Gluckman, Joseph E Marine, Roxana Mehran, Steven R Messe, Nimesh S Patel, Benjamin E Peterson, Kenneth Rosenfield, Sarah A Spinler, Vinod H Thourani

PMID: 33250267
DOI: 10.1016/j.jacc.2020.09.011

No abstract available

Keywords: ACC Expert Consensus Decision Pathway; DOAC; anticoagulant therapy; antiplatelet therapy; atherosclerotic cardiovascular disease; atrial fibrillation; percutaneous coronary intervention; venous thromboembolism.

Publication types

Practice Guideline

MeSH terms

Atrial Fibrillation / complications
Atrial Fibrillation / therapy*
Cardiology*
Cardiovascular Diseases / therapy
Consensus*
Humans
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors
Societies, Medical*
United States
Venous Thromboembolism / etiology
Venous Thromboembolism / prevention & control*

Substances

Platelet Aggregation Inhibitors